Therapeutic cloning: from consequences to contradiction.
The British Parliament legalized therapeutic cloning in December 2000 despite opposition from the European Union. The watershed event in Parliament's move was the active and unprecedented government support for the generation and destruction of human embryonic life merely as a means of medical advancement. This article contends that the utilitarian analysis of this procedure is necessary to identify the real world risks of therapeutic cloning but insufficient to identify the breach of defensible ethical limits that this procedure represents. A value-oriented approach to Kantian ethics demonstrates that the utilitarian endorsement of therapeutic cloning entails a contradiction of the necessity of human vulnerability and a faulty valuation of the human embryo. The concern is that a narrow utilitarian focus ultimately commodifies human embryonic life and preferences outcomes as the sole determinant of moral value.
Coors
Marilyn
M
University of Colorado Health Sciences Center B-137, 4200 East Ninth Avenue, Denver, CO 80262, USA. Marilyn.Coors@UCHSC.edu
D001709:Biotechnology / Q000592:standards*; D019976:Cloning, Organism / Q000331:legislation & jurisprudence / Q000592:standards*; D004622:Embryo, Mammalian / Q000166:cytology*; D028663:Ethical Theory; D004992:Ethics, Medical; D015316:Genetic Therapy / Q000592:standards*; D006801:Humans; D028681:Moral Obligations; D010686:Philosophy, Medical; D012106:Research; D013234:Stem Cells; D006113:United Kingdom
Analytical Approach; Biomedical and Behavioral Research; Genetics and Reproduction; Philosophical Approach